Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsors and Collaborators: |
Park Nicollet Institute International Diabetes Center LifeScan |
---|---|
Information provided by: | Park Nicollet Institute |
ClinicalTrials.gov Identifier: | NCT00202033 |
To determine if the frequency of blood glucose testing in patients with type 2 diabetes who are being treated with diet and exercise alone or diet and exercise plus oral agents will impact the HbA1c level.
Condition | Intervention | Phase |
---|---|---|
Type 2 Diabetes Referred to Comprehensive Diabetes Education Program |
Behavioral: frequency of self monitoring blood glucose |
Phase IV |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Open Label, Uncontrolled, Parallel Assignment, Safety/Efficacy Study |
Official Title: | Impact of Self-Monitoring Blood Glucose Frequency on Glycemic Control in Patients With Type 2 Diabetes |
Enrollment: | 150 |
Study Start Date: | September 2004 |
Estimated Study Completion Date: | June 2009 |
Estimated Primary Completion Date: | June 2009 (Final data collection date for primary outcome measure) |
Arms | Assigned Interventions |
---|---|
1: Experimental
self monitor blood glucose 3 times a day per usual diabetes class curriculum
|
Behavioral: frequency of self monitoring blood glucose |
2: Experimental
only self monitor blood glucose when fasting
|
Behavioral: frequency of self monitoring blood glucose |
3: Experimental
no self monitoring of blood glucose
|
Behavioral: frequency of self monitoring blood glucose |
To determine the impact of SMBG frequency on blood glucose control in patients receiving systematic diabetes management education through Type 2 Diabetes BASICS at International Diabetes Center.
Ages Eligible for Study: | 18 Years to 79 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
United States, Minnesota | |
International Diabetes Center | |
Minneapolis, Minnesota, United States, 55416 |
Principal Investigator: | Richard M Bergenstal, MD | Park Nicollet Institute/International Diabetes Center |
Responsible Party: | International Diabetes Center ( Richard M. Bergenstal, MD ) |
Study ID Numbers: | 01856-04-C |
Study First Received: | September 12, 2005 |
Last Updated: | January 13, 2009 |
ClinicalTrials.gov Identifier: | NCT00202033 History of Changes |
Health Authority: | United States: Park Nicollet Institute Institutional Review Board |
Metabolic Diseases Diabetes Mellitus, Type 2 Diabetes Mellitus Endocrine System Diseases |
Endocrinopathy Glucose Metabolism Disorders Metabolic Disorder |
Metabolic Diseases Diabetes Mellitus, Type 2 Diabetes Mellitus Endocrine System Diseases Glucose Metabolism Disorders |